These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6520482)

  • 1. [A study on clinical significance of oncofetal antigen-1 in gynecologic tumors].
    Takahashi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Dec; 36(12):2613-8. PubMed ID: 6520482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinical significance of antibody against oncofetal antigen-I in patients with gynecologic tumors].
    Higuchi M; Ohsawa S
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):25-30. PubMed ID: 2324586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of antibody against oncofetal antigen-I (anti-OFA-I) in patients with gynecologic tumors.
    Higuchi M; Takahashi M; Takeuchi Y; Hando T; Takeuchi S
    Asia Oceania J Obstet Gynaecol; 1986 Sep; 12(3):419-23. PubMed ID: 3778321
    [No Abstract]   [Full Text] [Related]  

  • 4. Oncofetal antigen: a tumor-associated fetal antigen immunogenic in man.
    Irie RF; Giuliano AE; Morton DL
    J Natl Cancer Inst; 1979 Aug; 63(2):367-73. PubMed ID: 88539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical significance of OFA-I in the immunological rejection mechanism in trophoblasts].
    Takeuchi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1893-8. PubMed ID: 3902999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of tumor antigens in gynecologic malignancies.
    Gall SA
    J Reprod Med; 1975 Jan; 14(1):12-6. PubMed ID: 162963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Importance of CA-50 detection in malignant gynecologic tumors].
    Indraccolo SR; Greco A; Cartechini MG; Compagnucci P
    Minerva Ginecol; 1990 Dec; 42(12):507-9. PubMed ID: 2089292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
    Ishiwata I; Ishiwata C
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor-associated antigens in gynecologic cancer.
    DiSaia PJ
    Clin Obstet Gynecol; 1975 Dec; 18(4):87-108. PubMed ID: 765038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncofetal antigen-I: distribution in human tumors.
    Rees WV; Irie RF; Morton DL
    J Natl Cancer Inst; 1981 Sep; 67(3):557-62. PubMed ID: 6268878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcino-embryogenic antigen (CEA) in patients with genital tumors (author's transl)].
    Anger H; Gleissenberger U
    Geburtshilfe Frauenheilkd; 1977 Jul; 37(7):604-8. PubMed ID: 885332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine excretion of tumor-associated antigens by patients with gynecologic neoplasms.
    Rote NS; Smith WG; Johnson GH
    Gynecol Oncol; 1980 Jun; 9(3):370-5. PubMed ID: 6991377
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of oncofetal antigen-I (OFA-I) on lymphocyte response in pregnant women].
    Kajino T; Kanazawa K; Takakuwa K; Sasagawa M; Maruhashi T; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):845-52. PubMed ID: 2942615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carcinoembryonic antigen in gynecological oncology].
    Stiglmayer R
    Fortschr Med; 1978 Oct; 96(37):1843-5. PubMed ID: 700565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
    Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunoglobulin level in malignant gynecologic diseases and tumor patients].
    Pulay T; Keller G; Krommer K; Kovács C
    Orv Hetil; 1973 Dec; 114(52):3146-8. PubMed ID: 4766323
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-embryoglycan antibodies detected in sera of patients with uterine cervical cancer].
    Kato Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):129-35. PubMed ID: 1690252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antibodies to the 27-kd heat shock protein in women with gynecologic cancers.
    Korneeva I; Bongiovanni AM; Girotra M; Caputo TA; Witkin SS
    Am J Obstet Gynecol; 2000 Jul; 183(1):18-21. PubMed ID: 10920302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study on tumor marker of tissue-polypeptide-antigen (TPA) in gynecologic malignancies].
    Nakajima H; Hirata T; Norisugi T; Furuno K; Ikehata N; Utsunomiya A; Kobayashi K; Negishi Y; Akiya K
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1877-83. PubMed ID: 6094688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.